SENATE-BILL 4512: S.4512 - Affordable Insulin Now Act of 2026
AI-Powered Summary
SENATE-BILL 4512 aims to enhance access to insulin for individuals with diabetes by mandating that health plans cover selected insulin products without deductibles and capping cost-sharing at $35 per 30-day supply. This legislation addresses critical healthcare access issues, particularly for uninsured individuals, by establishing a program to provide discounted insulin, thereby promoting equitable access to essential medication. Key provisions include the prohibition of deductibles for insulin, the creation of a reimbursement program for uninsured individuals, and clear definitions of what constitutes 'selected insulin products.' The implementation of these provisions may raise constitutional concerns regarding federalism and equal protection, as they could affect the balance of power between state and federal regulations and potentially favor certain groups in healthcare access. Overall, the bill seeks to reduce financial barriers to insulin access, ensuring that individuals can obtain necessary medications without incurring significant out-of-pocket costs.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant positive implications for individuals, particularly those who are uninsured or belong to lower-income demographics. It aims to reduce financial barriers to essential medications, thereby promoting health equity.
Key Individual Rights Affected
- Right to Health Care
- Equal Protection under the Law
Constitutional Provisions Most Relevant
- 14th Amendment - Equal Protection Clause
- U.S. Constitution, Preamble - General Welfare
Potential Constitutional Challenges Or Support
Support
The bill is likely to be supported as it addresses health care access disparities, particularly for marginalized groups.
Concerns
There may be challenges regarding federal overreach into state-regulated health care systems, particularly if states argue that the bill infringes on their rights to regulate health care.
Summary
The Affordable Insulin Now Act of 2026 is a legislative effort to ensure that individuals, regardless of their insurance status, have access to necessary insulin at an affordable price. By capping costs and providing support for uninsured individuals, the bill seeks to eliminate financial barriers to health care, thereby promoting equity and protecting individual rights. While it raises some concerns about federal authority, its overall impact aligns with constitutional principles of equal protection and public welfare.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 4512 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreeTimeline
May 13, 2026
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat